Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Obama - Clinton Disaster -- Ignore unavailable to you. Want to Upgrade?

To: Gersh Avery who wrote (97871)	4/9/2015 11:00:10 AM
From: Gersh Avery	Respond to of 103300

Drug companies are selling less derivatives of opium as a result. This translates into thousands of lives saved: 25% of those that would have died are now still alive. Which person that you know had their lives saved? You can't tell. Their lives were simply extended without any fanfare .. Only by looking at the statistics do you notice there are extra survivors. reset.me According to a report this year from the esteemed Journal of the American Medical Association (JAMA), fatal overdoses caused by prescription painkillers dropped dramatically in states where cannabis is legal for medical and recreational use. Access to medical cannabis, according to the study, is responsible for an overall 25% drop in fatalities associated with prescription drugs taken for chronic pain. The study also expects such fatalities to continue to drop as cannabis reform across the country allows more people to legally access the drug for medical purposes. Study authors in fact believe that people who have chronic pain tend to rely on medical cannabis when they have this option, which also dramatically reduces the risk of addiction and overdose of other used medications. “We think that people with chronic pain may be choosing to treat their pain with cannabis rather than with prescription painkillers, in states where this is legal,” said lead author Dr. Marcus Bachhuber, a researcher with the Center for Health Equity Research and Promotion at the Philadelphia Veterans Affairs Medical Center. The impact of this study, particularly for veterans as a result, might be significant in the next few years as some kind of federal reform becomes a more reachable goal. Such far reaching conclusions by respected medical researchers are also likely to play into policy decisions particularly over local bans and higher taxes in many states. With that said, research like the analysis in the JAMA study only adds to the debate about the necessity of access for medical patients to not only relieve their pain, but to shine light on the advantages, both personally and societally, of continuing to supply access to medicinal cannabis.